Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Clinical Genetics|June 18, 1998
Polymorphisms at the angiotensinogen (AGT) and angiotensin II type 1 receptor (AT1R) loci and normal blood pressureK E Berge, K BergClinical Genetics|April 1, 1994
No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variabilityK E Berge, K BergClinical Genetics|March 31, 1998
Cardiovascular risk factors in people with different genotypes in the insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme (ACE)K E Berge, K BergClinical Genetics|February 1, 1992
No effect of a Taq1 polymorphism in DNA at the endothelin I (EDN1) locus on normal blood pressure level or variabilityK E Berge, K BergClinical Genetics|December 1, 1994
No effect on blood pressure level or variability of polymorphisms in DNA at the locus for atrial natriuretic factor (ANF)K E Berge, K BergClinical Genetics|December 1, 1994
No effect of a BglI polymorphism at the renin (REN) locus on blood pressure level or variabilityK E Berge, K BergClinical Genetics|October 1, 1993
No effect of TaqI polymorphism at the human renal kallikrein (KLK1) locus on normal blood pressure level or variabilityK E Berge, K BergClinical Genetics|October 12, 2013
Genetics of hypertrophic cardiomyopathy in NorwayK E Berge, T P LerenAPMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 1, 1996
Interleukin-1 alpha, interleukin 6 and tumor necrosis factor alpha increase the synthesis and expression of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitroV Berge, E Johnson, K E BergeAPMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 1, 1996
Vitronectin modulates the expression of complement components of the terminal pathway synthesized by human umbilical vein endothelial cells in vitroV Berge, K E Berge, E JohnsonPageof 3